MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ADCT made $16,427K in revenue. -$40,966K in net income. Net profit margin of -249.38%.

Income Overview

Revenue
$16,427K
Net Income
-$40,966K
Net Profit Margin
-249.38%
EPS
-$0.3
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product revenues, net
    • License revenues and royalties

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenue, net
16,427 18,839 23,033 17,482
Cost of product sales
1,202 836 2,061 -
Research and development
26,803 30,090 28,928 26,418
Selling and marketing
10,688 10,147 10,553 11,321
General and administrative
8,326 8,822 9,955 10,827
Cost of product sales
---1,487
Restructuring and impairment expenses
377 13,091 --
Total operating expense
47,396 62,986 51,497 50,506
Interest expense
--12,230 -
Loss from operations
-30,969 -44,147 -28,464 -33,024
Interest income
2,470 1,934 2,054 3,136
Deferred royalty obligation interest expense
8,996 ---
Effective interest expense on senior secured term loan facility-Loan Agreement
4,396 ---
Interest expense
13,392 12,997 -12,553
Other, net
925 -182 203 4,040
Total other expense, net
-9,997 -11,245 -9,973 -5,377
Loss before income taxes
-40,966 -55,392 -38,437 -38,402
Income tax expense
0 1,254 165 -79
Loss before equity in net losses of joint venture
-40,966 -56,646 -38,602 -38,323
Equity in net losses of joint venture
0 0 --343
Net loss
-40,966 -56,646 -38,602 -38,666
Net loss per share, basic (in dollars per share)
-0.3 -0.5 -0.36 -0.41
Net loss per share, diluted (in dollars per share)
-0.3 -0.5 -0.36 -0.41
Weighted average shares outstanding, basic (in shares)
136,446,534 113,743,358 107,202,374 -51,678,078
Weighted average shares outstanding, diluted (in shares)
136,446,534 113,743,358 107,202,374 -51,678,078
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$40,966K Loss before equity innet losses of joint...-$40,966K Loss before incometaxes-$40,966K License revenues androyalties$677K Product revenues, net$15,750K Total other expense,net-$9,997K Loss from operations-$30,969K Other, net$925K Interest income$2,470K Total revenue, net$16,427K Interest expense$13,392K Total operatingexpense$47,396K Effective interestexpense on senior...$4,396K Deferred royaltyobligation interest...$8,996K Restructuring and impairmentexpenses$377K General andadministrative$8,326K Selling and marketing$10,688K Research and development$26,803K Cost of product sales$1,202K

ADC Therapeutics SA (ADCT)

ADC Therapeutics SA (ADCT)